MedTrace Logo

Clinical Significance of Assesment of Serum miRNA-30a in Childhood Nephrotic Syndrome

NCT03235128 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-08-02

No results posted yet for this study

Summary

Childhood nephrotic syndrome is the most frequent glomerular disease that presents during childhood,primarily owing to a disturbed immune function.This disease is characterized by alterations in selectivity at the glomerular capillary wall that lead to an inability to restrict the urinary loss of protein.

Conditions

  • Nephrotic Syndrome Steroid-Resistant

Interventions

DIAGNOSTIC_TEST

‗Urine analysis ‗Urine protein quantification ‗Serum albumin ‗Lipid profile.Quantitation of miRNA -30a by Real-time polymerase chain reaction (Q-PCR) in peripheral blood.

Specific tests Quantitation of miRNA -30a by Real-time polymerase chain reaction (Q-PCR) in peripheral blood

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2019-06-01
Completion
2019-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03235128 on ClinicalTrials.gov